País: Australia
Idioma: inglés
Fuente: Department of Health (Therapeutic Goods Administration)
metoclopramide hydrochloride, Quantity: 5 mg/mL
iNova Pharmaceuticals (Australia) Pty Ltd
Injection, solution
Excipient Ingredients: sodium chloride; water for injections
Intravenous, Intramuscular
10 X 2mL, 2 x 2mL
(S4) Prescription Only Medicine
INDICATIONS AS AT 10 AUGUST 1994: Adults (20 years and over): As an adjunct to X-ray examination of the stomach and duodenum. To assist in intestinal intubation. To control nausea and vomiting associated with the following conditions: intolerance to essential drugs possessing emetic properties; uraemia; radiation sickness; malignant disease; postoperative vomiting; labour; infectious diseases. There is no clear benefit in motion sickness or other labyrinth disturbances. Intramuscular administration of Maxolon facilitates the absorption of a range of drugs including the absorption of aspirin in people with migraine. Maxolon has been found useful in the management of gastric retention after gastric surgery. Maxolon may be useful in the treatment of diabetic gastroparesis of mild to moderate severity. Once control of diabetes has been established by diet and/or insulin, Maxolon should be discontinued. Young Adults and Children: The use of Maxolon in patients under 20 years should be restricted to the following s
Visual Identification: A clear solution free from particulate matter.; Container Type: Ampoule; Container Material: LDPE; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Registered
1992-06-12
MAXOLON ® _Metoclopramide hydrochloride_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Maxolon. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Maxolon against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT MAXOLON IS USED FOR In adults over 20 years this medicine is used to: • treat nausea and vomiting caused by infectious diseases, migraine, kidney disease, child birth, other medications, cancer, or following surgery, chemotherapy or radiation treatment. • activate stomach contractions in conditions where there is a need to encourage normal passage of food through the stomach and intestines. • with X-rays to help diagnose problems of the stomach and/or intestines. • help with passing tubes into the intestine. In young adults and children over 1 year of age this medicine is used to: • treat severe vomiting of known cause or following chemotherapy or radiation treatment. • help with passing tubes into the intestine. This medicine works by blocking the action of a chemical in the brain which causes nausea and vomiting. It also acts in the stomach and upper intestine to increase muscle contractions ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU OR YOUR CHILD. Your doctor may have prescribed it for another reason. BEFORE TAKING MAXOLON _WHEN YOU MUST NOT TAKE IT_ DO NOT TAKE MAXOLON IF YOU HAVE AN ALLERGY TO: • any medicine containing Metoclopramide • any of the ingredients listed at the end of this leaflet. Some of the symptoms of an allergic reaction may include: • shortness of breath • wheezing or difficulty breathing • swelling of the face, lips, tongue or other parts of the bod Leer el documento completo
1 AUSTRALIAN PRODUCT INFORMATION – MAXOLON (METOCLOPRAMIDE HYDROCHLORIDE) TABLETS AND INJECTION 1 NAME OF THE MEDICINE Metoclopramide hydrochloride 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Tablets: Metoclopramide 10 mg (as hydrochloride). Injection: Metoclopramide hydrochloride monohydrate 10 mg/2mL. Maxolon tablets contain lactose monohydrate. For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM Tablets: round biconvex, white tablets approximately 7mm in diameter with a break bar on one side and "MAXOLON" debossed on the other. Injection: A clear solution free from particulate matter 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS Adults (20 years and over)_ _ As an adjunct to X-ray examination of the stomach and duodenum. To assist in intestinal intubation. To control nausea and vomiting associated with the following conditions: intolerance to essential drugs possessing emetic properties; uraemia; radiation sickness; malignant disease; postoperative vomiting; labour; infectious diseases. There is no clear benefit in motion sickness or other labyrinth disturbances. Intramuscular administration of Maxolon facilitates the absorption of a range of drugs including the absorption of aspirin in people with migraine. Maxolon has been found useful in the management of gastric retention after gastric surgery. Maxolon may be useful in the treatment of diabetic gastroparesis of mild to moderate severity. Once control of diabetes has been established by diet and/or insulin, Maxolon should be discontinued. Young adults and children over 1 year of age The use of Maxolon in patients under 20 years should be restricted to the following situations and only used as second line therapy: Severe intractable vomiting of known cause. Vomiting associated with radiotherapy and intolerance to cytotoxic drugs. As an aid to gastrointestinal intubation. 2 4.2 D OSE AND METHOD OF ADMINISTRATION Patients with normal renal and hepatic function _ _The dosage recommendations given below should be str Leer el documento completo